ABOUT NEO
Company.
Computational discovery. Better research decisions.
We connect molecular design, evidence review and experimental planning. Meet the people and the purpose behind NEO Drug Discovery.
Better decisions before the next experiment.
NEO Drug Discovery connects molecular design, evidence review and experimental planning in one computational discovery platform.
From protein degraders to RNA-directed approaches and small molecules, we help research teams decide what to test—and understand why.
Team§ 06The people leading the company
Leadership
CEO
Jihae Lim
KICPA
Jihae Lim is Chief Executive Officer of NEO Drug Discovery, with a background spanning corporate finance, business operations and professional advisory services.
She has served as Chief Financial Officer and Chief Operating Officer at LVMH Perfumes & Cosmetics. Her experience as an accountant at leading accounting firms, including Deloitte and Baker Tilly, spans diverse industries and a broad range of audit and advisory engagements. We believe her breadth of experience and passion will make a meaningful contribution to our mission of advancing the frontiers of biotechnology.
CTO
Sang Hun Lee
MD, PhD
Sang Hun Lee is Chief Technology Officer of NEO Drug Discovery, with a background in academic medicine and cancer-center leadership. He is a professor at the University of Ulsan College of Medicine and serves as Director of the Regional Cancer Center at Ulsan University Hospital.
His academic career also includes a visiting-scholar appointment at the UC Irvine School of Medicine, complementing his experience in medical education and cancer care with an international academic perspective.
